Central-type primitive neuroectodermal tumor of the uterus: Case report of remission of stage IV disease using adjuvant cisplatin/etoposide/bevacizumab chemotherapy and review of the literature

• Bevacizumab was an effective agent in one case of advanced uterine PNET.
• VEGF was expressed by the tumor, supporting a mechanism for effectiveness.
• Cisplatin/etoposide/bevacizumab should be further studied in clinical trials.
• Patient remains disease-free forty-eight months following intervention.